In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian approaches in modern drug development, emphasizing their potential to improve ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results